Letter to the Editor: In Response to Hematology...Literally and Seriously
Dr. Rosenblum responds to The Hematologist Editor-in-Chief's commentary in the Year's Best issue.
A New Phase II Agent Holds Promise for First FDA Approved Therapy for Treatment of Acute Vaso-Occlusive Pain Events in SCD
Dr. DeBaun evaluates a new agent for the prevention of vaso-occlusive pain episodes in sickle cell disease that holds promise for first FDA approval since hydroxyurea.
Dr. Williams talks about ASH's influence in the development of precision medicine, which is a big part of the new ASH Research Agenda.
Dr. Williams highlights the many resources ASH provides to strengthen the field's research and drug discovery efforts.
Dr. Williams discusses ASH's international presence through various programs and initiatives; he highlights the need for support for several changes in governance and membership structure to help ASH advance as a global organization.
Dr. Williams discusses several ASH initiatives to help advance efforts to improve research, treatment, and outcomes for individuals with SCD.
Dr. Williams shines a spotlight on the scholarships and awards ASH makes possible each year, and the successes of the numerous winners.
Dr. David A. Williams introduces ASH's priorities for the coming year.
Over the past decade regenerative medicine has become a highly active area of investigation with the potential to address many unmet medical needs. Hematologists have played a prominent role in advancing this emerging field because of prior expertise in stem cell and transplantation biology as well as extensive experience in related areas of translational research. Despite the impetus for growth this field has experienced, investigators continue to face numerous challenges in conducting translational and clinical research in regenerative medicine and cell-based therapy.
March-April 2017Volume 14, Issue 2
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology